Ucwaningo Luthola I-Biologics Khombisa Ayikho Ingozi Ekhulayo Yomdlavuza Webele
Ingozi yomdlavuza webele
Ucwaningo aluboni ubufakazi bokuthi ukwelashwa kwamathambo e-rheumatoid kwandisa ingozi yomdlavuza webele, ikakhulukazi imishanguzo emisha. I-National Databank ye-Rheumatic Diseases (NDB) yanikeza ucwaningo kwi-European Congress of Rheumatology yonyaka we-European League Against Rheumatism (EULAR) ngo-2005.
Imithi emisha, eyaziwa ngokuthi i-biologic response modifiers noma i-biologics, ifaka izidakamizwa:
- I-Remicade (i-infliximab)
- Enbrel (etanercept)
- Huma (adalimumab)
Le mithi yayisithakazelo esikhethekile ngoba ukwelashwa okuningi okwandisa ukwandisa ingozi yamanye amagciwane e-rheumatoid arthritis (RA). Ucwaningo lwangaphambili lwe-NDB lwathola inhlangano phakathi komdlavuza wesikhumba we-biologics non-melanoma.
Ucwaningo luyaxwayisa ukuthi ngenxa yokuthi izidakamizwa ziye zaphela emakethe iminyaka embalwa, ukwehliswa kwesiguli emithwalweni kungase kube mfushane kakhulu ukuze kube nesiphetho esiqinile nokuthi ukuqhubeka nokutadisha kuzodingeka.
Yiziphi izinguquko ze-Biologic Response Modifiers?
Iziguquli ze-biologic response modifiers ziphakathi kwezidakamizwa ezintsha ezisetshenziselwa ukwelapha isifo samathambo. I-biologics imithi ephathelene namakhemikhali ayenziwe ngamaseli aphilayo. Ukwelashwa kwezinto eziphilayo kusebenzisa ama-modifiers okwenziwa yi-biologic ukuvuselela noma ukubuyisela amandla omzimba wokuvikela omzimba ukulwa nezifo kanye / noma ukutheleleka. I-biologics ingafaka:
- i-interferon
- interleukin-2
- izinhlobo ezehlukene zezici ezikhuthaza abantu
Imithi Enbrel, Remicade, ne-Humira, ihlose imiphumela ye-TNF-alpha. I-TNF-alpha ingenye ye-cytokines ebaluleke kakhulu ehilelekile ku-rheumatoid arthritis ngokusebenzisa ukungena kwayo ekuphendukeni kokuphendula okuvuthayo. I-TNF blockers ibophezela ku-TNF-alpha, iyenza ingasebenzi, futhi iphazamise umsebenzi wokuvuvukala, ekugcineni kwehlisa umonakalo ohlangene.
- I-Biologic DMARD
- I-Biologic Response Modifier: Kuyini?
Mayelana neSifundo
Lolu cwaningo, olubhalwa uDkt. Fred Wolfe noCaleb Michaud, lusebentisa ibanga lemininingwane yesifo se-rheumatic lesifo se-rhmumatic patients of 16,398, esasingazazi umdlavuza webele uma isifundo seqala. Iziguli zalandelwa iminyaka engaba ngu-6.
Ucwaningo alutholanga izinhlangano ezibalulekayo phakathi komdlavuza webele kanye namanje, ezandulela noma zokuphilisa i-RA zesikhathi eside, kuhlanganise ne-biologics kanye nemithi ejwayelekile kakhulu yezokwelapha kanye ne- corticosteroid . Ngaphezu kwalokho, akukho izinyathelo zokuqina kwesifo ezihlobene nomdlavuza webele. Ukuhlukahluka kwesibalo semvelo esilandelayo umdlavuza webele phakathi kweziguli ze-rheumatoid arthritis kuyinto yobudala, kanti amanani aphakeme kakhulu avela phakathi kweminyaka engama-55 no-70. Inkomba yokubhema nomzimba akutholakali ukubikezela.
Iyini Ingculaza Yengane?
Amagciwane ebelethweni angase abe nezinhlekelele ezisongela ukuphila eziqala ezingxenyeni zesifuba. Ngokusho kuka-ADAM, ngokuhamba kwesikhathi, owesifazane oyedwa kwabayisishiyagalombili uzotholakala enesifo somdlavuza webele. U-Faith Addiss ubhala ku- What Is Breast Cancer? , "Amakhansela amaningi asebele abhula kancane futhi ngesikhathi ihlumela lingazizwa, kungenzeka ukuthi landa iminyaka emihlanu noma eyishumi.
Umdlavuza webele wesifuba ngokuvamile awunayo izimpawu futhi ngaphambili kutholakala isisu, kungcono amathuba okusinda. "
Ukuze uthole ukwaziswa okwengeziwe nge-Cancer Breast:
Iyini i-National Databank ye-Rheumatic Diseases?
I-National Databank ye-Rheumatic Diseases (NDB) ingu-non-profit research databank eyenza ucwaningo olukhethekile lwangomtholampilo ngezifo ze-rheumatic. I-NDB okwamanje ifuna iziguli ezixilongwa nge- rheumatoid arthritis , i- osteoarthritis , i-fibromyalgia, i-lupus noma ezinye izimo ze-rheumatic.
Ucwaningo lwe-NDB lwenzelwe ukuthuthukisa ukwelashwa nemiphumela yalezi zimo. I-NDB yenza imiphumela yocwaningo ngokusebenzisana ngokuqondile neziguli ze-rheumatology.
Iziguli zibika ngazo zonke izici zokugula kwazo emibhalweni eningiliziwe yeminyaka yonke.
Umthombo: National Databank for Rheumatic Diseases, EULAR 2005 Press Release